Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
ShangPharma appoints Arthur Taveras as President and CSO
ShangPharma appoints Arthur Taveras as President and CSO
Taveras brings the experience of a 24-year career to the Chinese contract research organisation
Mylan appoints Jacek Glinka as President of its European Business
Mylan appoints Jacek Glinka as President of its European Business
The former Chief Executive of the Polpharma Group will take up the role on 2 December
Astellas adds to global development team
Astellas adds to global development team
Promotes Mark Weinberg to VP Global Clinical Science and appoints Robin McGarry as Head of Global Medical Safety
Former Chairman and CEO of Bayer France joins Neovacs
Former Chairman and CEO of Bayer France joins Neovacs
Miguel Sieler replaces Guy-Charles Fanneau De La Horie
Simcere Pharmaceutical Group appoints Chief Scientific Officer
Simcere Pharmaceutical Group appoints Chief Scientific Officer
Dr Zang Jingwu to lead research and development team
Cardio3 BioSciences strengthens management team
Cardio3 BioSciences strengthens management team
Hires Dr Gaëtane Metz as Chief Operating Officer
Results Healthcare appoints Nick Hyde as Managing Director
Results Healthcare appoints Nick Hyde as Managing Director
Life sciences industry veteran has been in the industry for more than 25 years
Catalent Applied Drug Delivery Institute adds Advisory Board member
Catalent Applied Drug Delivery Institute adds Advisory Board member
Professor Claus-Michael Lehr has spent more than 15 years in drug delivery research
Glenn Killingworth joins PCI as VP of Business Development
Glenn Killingworth joins PCI as VP of Business Development
Will drive business growth at the Newburyport, MA, US-based firm
Daiichi Sankyo makes two executive appointments
Daiichi Sankyo makes two executive appointments
Glenn Gormley and Greg Barrett are promoted at the US business
Actavis plc names Board of Directors
Actavis plc names Board of Directors
Following the finalisation of the takeover of Warner Chilcott
Nick Haggar of Sandoz to become new EGA President
Nick Haggar of Sandoz to become new EGA President
Takes up the role on 8 October
Results Healthcare announces further expansion into US market
Results Healthcare announces further expansion into US market
Executive Director Hemavli Bali relocates to New York
Olivier Brandicourt to become new CEO of Bayer HealthCare
Olivier Brandicourt to become new CEO of Bayer HealthCare
Former Pfizer executive joins the German pharmaceutical firm
Merck reorganises management team at Merck Serono biopharmaceutical division
Merck reorganises management team at Merck Serono biopharmaceutical division
Belén Garijo, currently Chief Operating Officer, has been appointed President and Chief Executive
Atlas Packaging appoints Operations Director
Atlas Packaging appoints Operations Director
Graham Campbell joins the UK firm from Ribble Packaging
Previous
1
…
135
136
137
138
(current)
139
140
141
…
213
Next
Trending Articles
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all